Comparison of The Chemours Company (CC) and Amyris Inc. (NASDAQ:AMRS)

As Specialty Chemicals businesses, The Chemours Company (NYSE:CC) and Amyris Inc. (NASDAQ:AMRS), are affected by compare. This especially applies to their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership.

Valuation and Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
The Chemours Company 6.64B 0.99 995.00M 5.37 7.06
Amyris Inc. 80.42M 2.73 212.61M -1.98 0.00

Table 1 demonstrates The Chemours Company and Amyris Inc.’s gross revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 has The Chemours Company and Amyris Inc.’s return on equity, return on assets and net margins.

Net Margins Return on Equity Return on Assets
The Chemours Company 14.98% 95.4% 13.4%
Amyris Inc. -264.37% 68% -127%

Risk & Volatility

A 2.2 beta indicates that The Chemours Company is 120.00% more volatile compared to Standard and Poor’s 500. Amyris Inc. on the other hand, has 0.41 beta which makes it 59.00% less volatile compared to Standard and Poor’s 500.

Liquidity

The Current Ratio and Quick Ratio of The Chemours Company are 1.9 and 1.3 respectively. Its competitor Amyris Inc.’s Current Ratio is 0.4 and its Quick Ratio is 0.4. The Chemours Company can pay off short and long-term obligations better than Amyris Inc.

Dividends

The Chemours Company shareholders receive an annual dividend of $0.84 per share which is subject to 2.16% dividend yield. No dividend is paid out by Amyris Inc.

Analyst Ratings

In next table is given The Chemours Company and Amyris Inc.’s ratings and recommendations.

Sell Ratings Hold Ratings Buy Ratings Rating Score
The Chemours Company 0 2 4 2.67
Amyris Inc. 0 0 0 0.00

The Chemours Company’s upside potential is 16.41% at a $46.17 consensus price target.

Institutional and Insider Ownership

Institutional investors held 82.3% of The Chemours Company shares and 40.4% of Amyris Inc. shares. 0.7% are The Chemours Company’s share held by insiders. Insiders Competitively, held 16.1% of Amyris Inc. shares.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
The Chemours Company -2.39% 6.04% 33.77% -15.38% -21.88% 34.34%
Amyris Inc. -2.04% 41.59% 1.05% -36.59% -8.92% 43.71%

For the past year The Chemours Company’s stock price has smaller growth than Amyris Inc.

Summary

The Chemours Company beats on 11 of the 13 factors Amyris Inc.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable ingredients. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and lubricants for industrial markets; Biofene ingredients for nutraceuticals and vitamins market; and renewable fuels for transportation fuels markets. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.